FDA NDC Directory · JSON-LD · Markdown

Rocklatan

NDC 70727-529 · HUMAN PRESCRIPTION DRUG · SOLUTION/ DROPS

Generic namenetarsudil and latanoprost ophthalmic solution, 0.02%/0.005%
Labeler / ManufacturerAlcon Laboratories, Inc.
Marketing categoryNew Drug Application (innovator) · App NDA208259
Dosage form / routeSOLUTION/ DROPS · OPHTHALMIC TOPICAL
Active ingredientsLATANOPROST (.05 mg/mL)
NETARSUDIL MESYLATE (.2 mg/mL)
Marketing started20190312
Package count2

External sources

Source: openFDA. Public-domain (CC0).